Literature DB >> 30283819

CADASIL affecting a black African man.

Louis Vlok1, Naeem Brey1.   

Abstract

Entities:  

Year:  2018        PMID: 30283819      PMCID: PMC6167179          DOI: 10.1212/NXG.0000000000000270

Source DB:  PubMed          Journal:  Neurol Genet        ISSN: 2376-7839


× No keyword cloud information.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an important genetic cause of strokes and vascular dementia.[1] The disease is characterized by 5 main symptoms: migraines, subcortical ischemic events, mood disturbances, apathy, and cognitive impairment. The causative mutation lies in the Notch3 gene on chromosome 19. The gene encodes for the NOTCH3 protein, which is expressed in vascular smooth muscle cells, and mutations lead to the development of arterial stenosis.[1] CADASIL has been described mostly in Caucasian families, but has been diagnosed infrequently in Arabian[2] and Asian families.[3] Only 1 case report on an African American family has been previously published.[4] There are no cases documenting indigenous black sub-Saharan African patients.

Case report

The patient is a 36-year-old black Zimbabwean man. He awoke one morning with right-sided hemiparesis. There was no history of a prior stroke-like episode. The patient denied social risk factors and reported occasional migraine-like headaches that started in his late twenties. There were no other significant medical or surgical comorbidities. He recalled that a paternal uncle previously had a stroke, while another paternal uncle was admitted to a psychiatric hospital and died of an unknown cause. He also noted that his paternal grandfather died of a stroke in his sixties. Unfortunately, most of his family was displaced because of the political unrest in Zimbabwe, and he had lost contact with them. On admission, the patient had normal vital signs and no evidence of cardiovascular disease. Neurologic examination showed intact language function. Examination of the motor system revealed a right hemiparesis, with symmetrical brisk reflexes. Sensation was normal, as was coordination. Laboratory tests, including full blood count, lipogram, fasting glucose, HIV serology, syphilis serology, antinuclear factor, and erythrocyte sedimentation rate were all normal. ECG, carotid Doppler, and transthoracic echocardiogram were normal. MRI detected T2 bilateral deep periventricular white matter hyperintensities. These lesions were especially confluent in the centrum semiovale (figure). There were also bilateral subcortical lesions in the anterior temporal lobes and diffuse cerebral atrophy.
Figure

T2 FLAIR images depict subcortical lesions in the anterior temporal lobes and deep white matter with confluent centrum semiovale hyperintensities

Given a history of migraines and a history of young-onset stroke in the patient's family, a diagnosis of CADASIL was considered. Molecular genetic analysis of the Notch3 gene was performed. This revealed a heterozygous missense mutation, which resulted in a substitution of a cysteine for serine amino acid at codon 183 within exon 4. The patient's family could not be tested as they remained in Zimbabwe at the time of diagnosis.

Discussion

Since the discovery of the Notch3 mutation in 1993, many patients with CADASIL have been identified worldwide. It is rare to identify a CADASIL mutation in a black indigenous African patient. However, the disease progression and imaging findings are typical, and the specific mutation has been previously identified in other confirmed cases.[5] Our patient is originally from the eastern highlands of Zimbabwe. This mountainous region range forms a natural border with neighboring Mozambique, which was previously a Portuguese colony. Although speculative, it is possible that the mutation could have been introduced by a Portuguese immigrant, accounting for how this typically Caucasian mutation was found in this patient. In addition, the specific mutation (c. 547 T > A; p. Cys183Ser) has also been described in other European families.[6] De novo mutations have been described in syndromic patients without a significant family history. Furthermore, CADASIL-causing mutations cluster in regions of sequence diversity and low evolutionary conservation.[7] Thus, the possibility exists that the mutation may have arisen spontaneously. In the correct clinical context, along with suggestive MRI findings, CADASIL could be considered in a young-onset stroke patient, regardless of his or her ancestry.
  7 in total

Review 1.  Interpretation of NOTCH3 mutations in the diagnosis of CADASIL.

Authors:  Julie W Rutten; Joost Haan; Gisela M Terwindt; Sjoerd G van Duinen; Elles M J Boon; Saskia A J Lesnik Oberstein
Journal:  Expert Rev Mol Diagn       Date:  2014-06       Impact factor: 5.225

2.  Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains.

Authors:  M Dichgans; H Ludwig; J Müller-Höcker; A Messerschmidt; T Gasser
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

3.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy affecting an African American man: identification of a novel 15-base pair NOTCH3 duplication.

Authors:  Soo Jung Lee; He Meng; Omar Elmadhoun; Mila Blaivas; Michael Mei-Hwa Wang
Journal:  Arch Neurol       Date:  2011-12

4.  Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL.

Authors:  Christine P Donahue; Kenneth S Kosik
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

Review 5.  Cadasil.

Authors:  Hugues Chabriat; Anne Joutel; Martin Dichgans; Elizabeth Tournier-Lasserve; Marie-Germaine Bousser
Journal:  Lancet Neurol       Date:  2009-07       Impact factor: 44.182

6.  Identification of a known mutation in Notch 3 in familiar CADASIL in China.

Authors:  Zhen-Xuan Tan; Fei-Feng Li; You-Yang Qu; Ji Liu; Gui-Rong Liu; Jin Zhou; Yu-Lan Zhu; Shu-Lin Liu
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  CADASIL in Arabs: clinical and genetic findings.

Authors:  Saeed Bohlega; Asmahan Al Shubili; Abdulrahman Edris; Abdulrahman Alreshaid; Thamer Alkhairallah; M Walid AlSous; Samir Farah; Khaled K Abu-Amero
Journal:  BMC Med Genet       Date:  2007-11-09       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.